The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGVP.L Regulatory News (GVP)

  • There is currently no data for GVP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Open Letter to Associated Capital Group, Inc.

15 Oct 2020 17:46

Metage Capital Limited - Open Letter to Associated Capital Group, Inc.

Metage Capital Limited - Open Letter to Associated Capital Group, Inc.

PR Newswire

London, October 15

Metage Capital Limited: open letter to Associated Capital Group, Inc.

Mr Bruce LismanAssociated Capital Group, Inc.191 Mason StreetGreenwich, CT 06830

For Immediate Release

15th October 2020

Dear Mr Lisman,

Re: respecting the vote by shareholders to discontinue the Gabelli Value Plus+ Trust Plc. (“GVP”)

On 6th October 2020 you held a webinar setting out the position of Associated Capital Group, Inc. (“ACG”) on the continuation of GVP. When signing up to this webinar, investors were asked to submit questions, however none were addressed. We have been dissatisfied by the subsequent response from ACG to the questions that we asked and believe that other shareholders would share similar queries. We therefore ask you to respond publicly to the following:

1. In the GVP announcement of 6th October, the Board of GVP refers to “…a letter received by the Board from the general counsel to ACG on 2 October 2020 indicating that (unspecified) litigation concerning the company may be a distinct possibility…” Can you please explain why ACG is threatening legal action, what potential illegality or breach of contract you perceive and what the aim of this litigation would be?

2. The “Magna Carta of shareholder Rights” on Gabelli Investors, Inc.’s website[1] states that it is in favour of “one share: one vote” and that “…we will vote against…supermajority voting…” How is attempting to frustrate the will of a clear majority of shareholders consistent with Gabelli’s corporate governance principles?

3. The Board has offered the potential of an in specie redemption of ACG’s pro rata share of the GVP portfolio or the ability to provide ACG with a roll over vehicle with a similar strategy and manager. This would enable ACG to continue its investment without frustrating the desire of other shareholders for a cash exit. How would you justify attempting to trap the majority of shareholders against their will?

Finally we would like to thank the Board of GVP for their steadfastness in a difficult situation, which is an excellent demonstration of the highest standards of corporate governance in London-listed investment trusts.

Yours faithfully,Tom Sharp, DirectorMetage Capital LimitedPrinces House, 38 Jermyn Street, London SW1Y 6DN, United KingdomEmail: tom.sharp@metage.comTel: +(44) 203 813 8590

[1] https://www.gabelli.co.uk/wp-content/uploads/2015/01/magnacarta092403.pdf

Date   Source Headline
3rd Jun 20219:49 amRNSNet Asset Value(s)
2nd Jun 20219:51 amRNSNet Asset Value(s)
1st Jun 20218:34 amRNSNet Asset Value(s)
28th May 20219:00 amRNSNet Asset Value(s)
27th May 20219:41 amRNSNet Asset Value(s)
26th May 20219:00 amRNSNet Asset Value(s)
25th May 20219:00 amRNSNet Asset Value(s)
24th May 20219:00 amRNSNet Asset Value(s)
21st May 20219:00 amRNSNet Asset Value(s)
20th May 20219:00 amRNSNet Asset Value(s)
19th May 20219:00 amRNSNet Asset Value(s)
18th May 20219:28 amRNSNet Asset Value(s)
17th May 20219:00 amRNSNet Asset Value(s)
14th May 20219:00 amRNSNet Asset Value(s)
13th May 20219:00 amRNSNet Asset Value(s)
12th May 20219:48 amRNSHolding(s) in Company
12th May 20219:01 amRNSNet Asset Value(s)
11th May 202110:21 amRNSNet Asset Value(s)
10th May 20219:00 amRNSNet Asset Value(s)
7th May 20219:12 amRNSNet Asset Value(s)
6th May 20219:00 amRNSNet Asset Value(s)
5th May 20219:00 amRNSNet Asset Value(s)
4th May 20219:41 amRNSNet Asset Value(s)
30th Apr 20219:00 amRNSNet Asset Value(s)
29th Apr 20219:00 amRNSNet Asset Value(s)
28th Apr 20219:00 amRNSNet Asset Value(s)
27th Apr 20219:00 amRNSNet Asset Value(s)
26th Apr 20219:00 amRNSNet Asset Value(s)
23rd Apr 20219:00 amRNSNet Asset Value(s)
22nd Apr 20219:00 amRNSNet Asset Value(s)
21st Apr 20219:00 amRNSNet Asset Value(s)
20th Apr 20219:00 amRNSNet Asset Value(s)
19th Apr 20219:00 amRNSNet Asset Value(s)
16th Apr 20219:00 amRNSNet Asset Value(s)
15th Apr 20219:00 amRNSNet Asset Value(s)
14th Apr 20211:44 pmRNSHolding(s) in Company
14th Apr 20219:52 amRNSNet Asset Value(s)
13th Apr 202110:15 amRNSNet Asset Value(s)
12th Apr 20219:00 amRNSNet Asset Value(s)
9th Apr 20219:28 amRNSNet Asset Value(s)
8th Apr 20219:00 amRNSNet Asset Value(s)
7th Apr 202110:30 amRNSNet Asset Value(s)
6th Apr 20214:00 pmRNSListing Rule 15.6.8
6th Apr 20219:00 amRNSNet Asset Value(s)
1st Apr 20219:00 amRNSNet Asset Value(s)
31st Mar 20211:15 pmRNSHolding(s) in Company
31st Mar 202112:00 pmRNSHolding(s) in Company
31st Mar 20219:10 amRNSNet Asset Value(s)
30th Mar 20219:00 amRNSNet Asset Value(s)
29th Mar 202110:30 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.